Metcalfe David A
- SEC CIK
- 0001664295
No open-market purchases or sales filed in the past year.
Current role at each company
- NXGN Nextgen Healthcare, Inc.Chief Technology Officeras of Dec 28, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Metcalfe David A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Metcalfe David AChief Technology Officer | SSale | −32.4K | $20.58 | −$666.2K | −16.7%161.2K after | |
| Nov 2, 2022 (view filing) | Nov 1 | 1 day | Metcalfe David AChief Technology Officer | SSale | −32.4K | $20.00 | −$647.4K | −15.3%179.0K after | |
| Oct 28, 2022 (view filing) | Oct 26 | 2 days | Metcalfe David AChief Technology Officer | SSale | −32.4K | $20.21 | −$654.2K | −17.9%148.8K after | |
| May 4, 2022 (view filing) | May 3 | 1 day | Metcalfe David AChief Technology Officer | SSale | −33.8K | $20.00 | −$676.8K | −17.9%155.0K after | |
| Apr 26, 2022 (view filing) | Apr 25 | 1 day | Metcalfe David AChief Technology Officer | SSale | −33.8K | $20.11 | −$680.5K | −17.9%155.0K after |